在临床局部性前列腺癌的咨询中,根据专业讨论的内容的变化
Nadine A Friedrich1, Michael Luu2, Rebecca Gale3
1Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Urologic oncology
|May 18, 2024
概括
专家在前列腺癌咨询期间讨论不同的话题. 泌尿科医生更多地关注预后,而医学和放射瘤学家则强调共享决策 (SDM). 放射性瘤学家应该增加对竞争风险的讨论.
科学领域:
- 在瘤学瘤学.
- 医学沟通 医学沟通
- 医疗保健服务研究 医疗服务研究
背景情况:
- 多学科咨询有助于改善前列腺癌 (PC) 治疗决策.
- 然而,不同专家讨论的具体内容仍然不清楚.
研究的目的:
- 分析和比较在泌尿器科,放射瘤学和医学瘤学专业的前列腺癌咨询期间讨论的叙事内容.
- 确定特定主题的时间分配的差异,包括共享决策 (SDM).
主要方法:
- 录音并转录了50次前列腺癌治疗咨询.
- 使用开放式编码方法,为8个叙事内容区域编码对话.
- 量化了每个内容领域所花费的时间,并使用多变量波桑回归来分析各专业之间的差异.
主要成果:
- 在癌症预后,竞争风险,治疗选择和SDM所花费的时间上出现了显著的差异.
- 泌尿科医生将更多的时间用于癌症预后,而医学和辐射瘤学家则将更多的时间用于SDM.
- 泌尿科医生和医疗瘤学家讨论了比放射瘤学家更多的竞争风险.
结论:
- 专家在前列腺癌咨询期间专注于不同的内容领域.
- 建议包括泌尿科医生增加SDM重点和放射瘤学家讨论竞争风险.
- 医疗瘤学家在促进SDM方面发挥着关键作用.
相关概念视频
01:20Disorders of the Male Reproductive System
395
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
395
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:27Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K